Enzyme-instructed assembly of a cholesterol conjugate promotes pro-inflammatory macrophages and induces apoptosis of cancer cells.
Yuan HuHuaimin WangChenge LiJinyao LiuBing XuWen DiPublished in: Biomaterials science (2020)
The combination of immunotherapy and chemotherapy has shown great potential for treating solid tumors. Although various combination therapy regimens have been demonstrated to be effective, their implementation in practice always needs separate drugs or modalities, which in turn requires specific and complicated operation procedures. Here, we describe the use of enzyme-instructed self-assembly (EISA) of a phosphotyrosine-cholesterol (PTC) conjugate to combine immune microenvironment modulation and chemotherapy. The enzymatic dephosphorylation of PTC results in the assembly of its derivatives inside and outside the cells, which leads to repolarization of the macrophage phenotype and direct death of cancer cells. The generation of reactive oxygen species and actin disturbance induced by the assemblies has been verified relative to the macrophage repolarization. We also demonstrate its dual repolarization and inhibition effects in vivo using an ovarian cancer bearing immunocompetent murine model. The EISA of cholesterol conjugates is an effective yet simple approach for the combination of tumor microenvironment immunomodulation and chemotherapy.
Keyphrases
- combination therapy
- low density lipoprotein
- locally advanced
- reactive oxygen species
- primary care
- cancer therapy
- healthcare
- adipose tissue
- induced apoptosis
- stem cells
- quality improvement
- squamous cell carcinoma
- chemotherapy induced
- cell cycle arrest
- hydrogen peroxide
- rectal cancer
- signaling pathway
- nitric oxide
- drug delivery
- risk assessment
- endoplasmic reticulum stress
- climate change
- living cells
- human health
- cell migration
- drug induced
- quantum dots